eliglustat
Selected indexed studies
- Eliglustat. (, 2006) [PMID:32352701]
- Eliglustat Therapy and CYP2D6 Genotype. (, 2012) [PMID:33351401]
- Eliglustat. (, 2012) [PMID:31644156]
_Worker-drafted node — pending editorial review._
Connections
eliglustat is a side effect of
Sources
- Eliglustat. (2006) pubmed
- Eliglustat Therapy and CYP2D6 Genotype. (2012) pubmed
- Eliglustat. (2012) pubmed
- Eliglustat: first global approval. (2014) pubmed
- Eliglustat: A Review in Gaucher Disease Type 1. (2015) pubmed
- Long-term effectiveness of eliglustat treatment: A real-world analysis from the International Collaborative Gaucher Group Gaucher Registry. (2024) pubmed
- Suicidal attempt with eliglustat overdose. (2023) pubmed
- Eliglustat tartrate for the treatment of adults with type 1 Gaucher disease. (2015) pubmed
- Inhibition of glycosphingolipid synthesis with eliglustat in combination with immune checkpoint inhibitors in advanced cancers: preclinical evidence and phase I clinical trial. (2024) pubmed
- Recommendations for the use of eliglustat in the treatment of adults with Gaucher disease type 1 in the United States. (2016) pubmed